236 related articles for article (PubMed ID: 29956068)
1. Interleukin-37 Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
Li Y; Gao Q; Xu K; Peng X; Yuan X; Jiang W; Li M
Inflammation; 2018 Oct; 41(5):1772-1779. PubMed ID: 29956068
[TBL] [Abstract][Full Text] [Related]
2. Lentivirus expressing soluble ST2 alleviates bleomycin-induced pulmonary fibrosis in mice.
Gao Q; Li Y; Pan X; Yuan X; Peng X; Li M
Int Immunopharmacol; 2016 Jan; 30():188-193. PubMed ID: 26604088
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-38 overexpression prevents bleomycin-induced mouse pulmonary fibrosis.
Xu Z; Yuan X; Gao Q; Li Y; Li M
Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):391-399. PubMed ID: 32577797
[TBL] [Abstract][Full Text] [Related]
4. STY39, a novel alpha-melanocyte-stimulating hormone analogue, attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice.
Xu PB; Mao YF; Meng HB; Tian YP; Deng XM
Shock; 2011 Mar; 35(3):308-14. PubMed ID: 20926985
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells mediate the release of interferon gamma-induced protein 10 and alleviate bleomycin-induced lung inflammation and fibrosis.
How CK; Chien Y; Yang KY; Shih HC; Juan CC; Yang YP; Chiou GY; Huang PI; Chang YL; Chen LK; Wang CY; Hsu HS; Chiou SH; Lee CH
Shock; 2013 Mar; 39(3):261-70. PubMed ID: 23364435
[TBL] [Abstract][Full Text] [Related]
6. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
[TBL] [Abstract][Full Text] [Related]
7. A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis.
Baowen Q; Yulin Z; Xin W; Wenjing X; Hao Z; Zhizhi C; Xingmei D; Xia Z; Yuquan W; Lijuan C
Eur J Pharmacol; 2010 Sep; 642(1-3):134-9. PubMed ID: 20510684
[TBL] [Abstract][Full Text] [Related]
8. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.
Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J
J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439
[TBL] [Abstract][Full Text] [Related]
9. Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis.
Grabarz F; Aguiar CF; Correa-Costa M; Braga TT; Hyane MI; Andrade-Oliveira V; Landgraf MA; Câmara NOS
Inflammopharmacology; 2018 Apr; 26(2):491-504. PubMed ID: 28779430
[TBL] [Abstract][Full Text] [Related]
10. Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis.
Zhao L; Wang X; Chang Q; Xu J; Huang Y; Guo Q; Zhang S; Wang W; Chen X; Wang J
Eur J Pharmacol; 2010 Feb; 627(1-3):304-12. PubMed ID: 19909737
[TBL] [Abstract][Full Text] [Related]
11. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
12. [Blocking IL-17A protects against lung injury-induced pulmonary fibrosis through promoting the activation of p50NF-kappaB].
Mi S; Li Z; Liu H; Hu ZW; Hua F
Yao Xue Xue Bao; 2012 Jun; 47(6):739-44. PubMed ID: 22919721
[TBL] [Abstract][Full Text] [Related]
13. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
Sakamoto H; Zhao LH; Jain F; Kradin R
Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
[TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
[TBL] [Abstract][Full Text] [Related]
15. (Z)-5-(4-Methoxybenzylidene)thiazolidine-2,4-dione, a novel readily available and orally active glitazone, attenuates the bleomycin-induced pulmonary fibrosis in vivo.
Wang G; Qi B; Zheng H; Chen Z; Wei X; Ma L; Ma Y; Wei Y; Luo Y; Chen L
Biol Pharm Bull; 2011; 34(2):219-25. PubMed ID: 21415531
[TBL] [Abstract][Full Text] [Related]
16. Glaucocalyxin A improves survival in bleomycin-induced pulmonary fibrosis in mice.
Yang F; Cao Y; Zhang J; You T; Zhu L
Biochem Biophys Res Commun; 2017 Jan; 482(1):147-153. PubMed ID: 27816453
[TBL] [Abstract][Full Text] [Related]
17. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
18. Iguratimod ameliorates bleomycin-induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase-9.
Zhao L; Mu B; Zhou R; Cheng Y; Huang C
Int J Rheum Dis; 2019 Apr; 22(4):686-694. PubMed ID: 30666825
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Jin M; Wang L; Wu Y; Zang BX; Tan L
Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
